Introduction
Inflammatory bowel disease is a chronic and relapsing inflammatory disease of the digestive tract comprising of two main sub-types: ulcerative colitis (UC) and Crohn's disease (CD). UC and CD differ by the intestinal localization and features of the inflammation, and have a similar prevalence of 100-150 per 100,000 individuals in populations of European ancestry (reviewed in (Khor, Gardet, Xavier 2011)) . IBD is thought to result from a combination of genetic and environmental risk factors. In recent years, genome-wide association studies (GWAS) and meta-analyses have identified 71 and 47 susceptibility loci for CD and UC, respectively, with several variants being shared between the two diseases. Although these findings have provided valuable information into the molecular pathways underlying the pathogenesis of IBD, a large part of genetic risk factors remain to be identified, as testified by the fact that known CD and UC variants explain less than 25% of disease heritability (Khor, Gardet, Xavier 2011) . A portion of missing risk loci is likely to be accounted for by common variants with modest effect, which have been treated as falsenegatives in GWAS. Indeed, the heavy multiple test correction inherent in genome-wide analysis is likely to discard several true-positive associations, suggesting that leveraging GWAS results with other types of data might allow the identification of additional risk variants.
Previous analyses have indicated that polymorphisms associated with autoimmune diseases have been targets of natural selection (Abadie et al. 2011; Barreiro and Quintana-Murci 2010; Corona, Dudley, Butte 2010; Fumagalli et al. 2009a; Fumagalli et al. 2009b; Fumagalli et al. 2011; Zhernakova et al. 2010) ; specifically, the selective pressure exerted by infectious agents has modulated the frequency of a subset of risk alleles for autoimmune or chronic inflammatory conditions, including CD and UC (Fumagalli et al. 2009b; Fumagalli et al. 2011) . Moreover, CD risk alleles have been shown to represent targets of recent positive selection (Corona, Dudley, Butte 2010) . Nonetheless, the proportion of IBD risk loci that has been targeted by pathogen-driven selection, as well as the type of infectious agent(s) which exerted the strongest pressure, remain to be evaluated. Moreover, the relationship between past selection and modern susceptibility to autoimmunity is often complex and variable depending on the disease and the loci being investigated . Also, the question remains open as to whether selection signatures can be exploited in the identification of novel susceptibility alleles for autoimmune diseases. A similar approach has been previously applied to increase power to detect malariaresistance variants (Ayodo et al. 2007 ), but not to autoimmune risk loci. Also, it has been recently shown that the long-term evolutionary conservation scores at polymorphic genomic positions relates to the odds ratio of GWAS associations, with SNPs at more conserved positions showing stronger effect sizes (Dudley et al. 2012) . Thus, the integration of evolutionary consideration with at UNIVERSITY OF ARIZONA on February 12, 2013 http://mbe.oxfordjournals.org/ Downloaded from large-scale association studies was suggested (Dudley et al. 2012 ).
Herein, we first evaluated how different pathogens have targeted known IBD susceptibility variants, and then used this information for prioritizing GWAS SNPs for replication in an independent cohort, resulting in the identification of three bona-fide novel susceptibility loci.
Results

GWAS SNPs for CD are preferential targets of protozoa-driven selection
We have previously shown that a subset of susceptibility alleles for inflammatory bowel disease (IBD) has been a target of pathogen-driven selection (Fumagalli et al. 2009b ). This original observation was restricted to the analysis of SNPs located within genes encoding interleukins and their receptors, and relied on the use of micro-pathogen diversity in distinct geographic areas as a measure of pathogen-driven selective pressure (Fumagalli et al. 2009b ). Subsequent works have indicated that the selective pressure exerted by distinct pathogen groups can at least partially be disentangled (Fumagalli et al. 2010a; Fumagalli et al. 2010b; Fumagalli et al. 2011; Pozzoli et al. 2010; Prugnolle et al. 2005) . Thus, we first wished to assess whether additional susceptibility variants for IBD are natural selection targets and whether specific pathogens have shaped their allele frequency. To this aim, we estimated pathogen-driven selection for single SNPs in the Human Genome Diversity Project (HGDP)-CEPH panel (Li et al. 2008 ) by calculating Kendall's rank correlation coefficient () between the diversity of virus, protozoan, bacterium or helminth species transmitted in distinct geographic locations and the allele frequency for the populations living in those same areas (Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Pozzoli et al. 2010; Prugnolle et al. 2005) . Each SNP was assigned a percentile rank in the distribution of  values calculated for all SNPs having a minor allele frequency (MAF) similar (in the 1% range) to that of the SNP being analysed (Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Pozzoli et al. 2010 ). We considered a SNP to be significantly associated with pathogen diversity if it displayed a rank higher than 0.95; this approach has the advantage of resulting in the same number of variants associated with the 4 pathogen groups. We next retrieved all GWAS SNPs associated to any trait or disease from the National Human Genome Research Institute (NHGRI) Catalog of Published Genome-Wide Association Studies (Hindorff et al. 2009 ), and collapsed SNPs in tight linkage disequilibrium (LD, r and UC variants to be correlated with the diversity of each pathogen group. Conversely, the percentage of CD SNPs that were significantly associated with virus, bacterium, protozoan and helminth diversity were 11.6, 4.6, 18.6 and 6.9 (Tab. 1, Suppl. Tab. S1), respectively, suggesting a strong enrichment for SNPs targeted by protozoa-driven selection. For UC, a percentage of SNPs close to 5% correlated with the diversity of each pathogen group (Tab. 1, Suppl. Tab. S1).
In order to assess whether the number of CD SNPs associated with protozoa diversity was significantly higher than expected, we applied a re-sampling approach on the 2773 GWAS SNPs.
By performing 10,000 re-samplings of 43 randomly selected MAF-matched SNPs we verified that the empirical probability of obtaining 8 variants significantly associated with protozoan diversity amounted to 0.0078 (Tab. 1), indicating that CD SNPs are preferential targets of protozoa-driven selection. A similar results was obtained when we compared CD SNPs to GWAS variants that have been identified as susceptibility loci for immune-mediated or infectious diseases/traits (Suppl. Tab. S2) (p= 0.0003, Tab. 1). Conversely, the number of CD SNPs that correlated with the diversity of virus, bacterium and helminth species was not different from expected (Tab.1).
Correlation with pathogen-diversity and, in general, approaches that exploit environmental variables to detect selection signatures have been shown to be reliable and robust to demographic effects (Hancock et al. 2008; Hancock et al. 2010; Hancock et al. 2011; Pozzoli et al. 2010) . Nonetheless, to confirm our results using a different test for selection, we calculated population genetic differentiation (measured as F ST (Wright 1950) ) for CD variants that were found to be or to be not targeted by protozoa-driven selection. Specifically we used the 1000 Genomes Pilot Project data to obtain F ST values for the Yoruba/European, Yoruba/Asian, and European/Asian comparisons. F ST values for CD SNPs were compared to the distribution of F ST calculated for variants deriving from ~1000 randomly selected genes (see methods). Results indicated that 6 out of 8 CD SNPs (75%) targeted by protozoa-driven selection displayed F ST values higher than the 95th percentile in at least one comparison (Fig. 1) ; for CD SNPs that were not found to correlate with protozoa diversity this proportion amounted to 31.4% (11 out of 35) (Fig. 1) , which may still be higher than expected, in line with the observation that CD SNPs represent preferential selection targets (Corona, Dudley, Butte 2010) , being the underlying pressure represented by protozoa or not. Given the results described above, we wished to assess whether, in single GWAS or meta-analyses, SNPs targeted by protozoa-driven selection display stronger association with CD compared to variants that have not been subject to this selective pressure. For this purpose, we retrieved association p values for the WTCCC1 (Wellcome Trust Case Control Consortium 2007) and NIDDK (Rioux et al. 2007 ) GWAS for CD, as well as for a meta-analysis of these two studies plus a third Belgian/French cohort (Barrett et al. 2008 ). The WTCCC1 and NIDDK studies were performed on subjects of British and USA/Canadian origin, respectively using different platforms; thus, the studies have few SNPs in common. We compared the association p values of protozoa selected and non-selected SNPs by the use of quantile-quantile (Q-Q) plots. As shown in figure 2 (a and b), in both CD GWASs and Barrett's meta-analysis, association values for protozoa-selected SNPs were stronger than for non-selected variants. This same behavior was not observed for several GWAS of other autoimmune diseases (Fig. 2a) . In order to provide confidence intervals for the observed shift in association p values in the CD meta-analysis, we applied a moving block bootstrap (MBB) procedure (see methods). This is devised to account for the non-independence of SNPs (due to LD), which might be even more pronounced in regions that have been targeted by natural selection Keinan and Reich 2010) . As shown in figure 2b , the upper edge of the confidence interval is below the diagonal identity line for most p value ranges, indicating that SNPs selected by protozoa have significantly stronger association with CD compared to variants that have not been targeted by protozoa-driven selection.
The power to detect association with a trait also depends on the SNP frequency in the population being analyzed. The average MAF (over all HGDP-CEPH populations) was slightly lower for protozoa-selected compared to non-selected variants (mean MAF = 0.250 and 0.266, respectively) included in Barrett's meta-analysis. Nonetheless, MAF calculation in subjects from Europe only (Barrett's meta-analysis included GWASs conducted in Europeans) revealed the opposite situation, with SNPs targeted by protozoa-driven selection (mean MAF in Europeans= 0.268) having, on average, higher MAF than non-selected SNPs (mean MAF in Europeans= 0.256; Wilcoxon Rank Sum test, p<0.001). Therefore, to rule out the possibility that the stronger association of SNPs selected by protozoa with CD ( Fig. 2b ) is secondary to a frequency bias, we reanalyzed Barrett's data taking MAF into account. In particular, we first LD-pruned (with r 2 > 0.8) the meta-analysis variants included in the HGDP-CEPH panel, and we next Q-Q plotted the association p values of protozoa-selected and non-selected variants. The same analysis was performed for 1,000 random samples of variants from the LD-pruned set and matched for MAF (calculated in Europeans only) with protozoa-selected variants. These samples were used to obtain the 5th and 95th percentiles across p value quantiles. As shown in figure 2c, protozoa selected SNPs show stronger association with CD compared to MAF-matched randomly selected variants.
Protozoa-driven selection allows identification of novel bona fide CD susceptibility loci
In the CD meta-analysis described above the authors set a threshold p value of 5×10
-5 for SNP follow-up, although variants with less significant association might well represent false-negatives (Barrett et al. 2008) . Given the results obtained, we reasoned that true-positive associations might be enriched among SNPs that display signatures of protozoa-driven selection and do not reach the meta-analysis threshold for significance. Thus, we first assessed whether protozoa-selected SNPs with nominally significant p value (i.e. 0.05<p value<5×10 -5 ) in Barrett's meta-analysis would have a better chance of being identified as CD-associated in a more powerful meta-analysis of 6 studies (Franke et al. 2010) compared to variants that display no correlation with protozoa diversity. A total of 44898 polymorphisms had a p value in the range of 0.05 to 5×10 -5 in Barrett's meta-analysis and were analysed by Franke and co-workers (Franke et al. 2010) ; of these 1284 showed association with protozoa diversity. The fraction of variants that reached genome-wide significance (i.e. p < 5x10 -8
) in the 6-study meta-analysis resulted to be 0.99% and 0.41% for protozoa -associated and -non associated variants, respectively. Although these variants cannot be regarded as independent, a more than two-fold enrichment is observed for protozoa selected SNPs.
We next explored the possibility of integrating selection signatures with meta-analysis results to identify novel susceptibility variants for CD. To this aim we exploited the 3-study meta-analysis for variant selection so that the association results could be combined with the partially independent 6-study meta-analysis. (Tab. 2), while no association is observed for the two remaining SNPs. The 3 significant SNPs are located in ARHGEF2 (Rho/Rac guanine nucleotide exchange factor 2), NSF (N-ethylmaleimide-sensitive factor), and HEBP1 (heme binding protein 1).
In order to verify whether the identified genes functionally interact, we applied Unsupervised Ingenuity Pathway Analysis (IPA). The three genes carrying variants associated with CD were used as input, and IPA identified two networks. One network (Fig. 3 ) contains ARHGEF2 and NSF plus VAMP3, a gene previously associated with CD in a recent meta-analysis of GWAS studies (Franke et al. 2010) . The second network contains HEBP1 only among the input genes (not shown).
Discussion
In recent years, the increasing availability of human genetic variation data allowed large-scale analysis of genomic regions subject to the selective pressure exerted by the environment. The identification of polymorphisms that strongly correlate in frequency with environmental variables has turned out as a powerful strategy to identify signatures of local adaptation to climate, dietary regimes and infectious agents (Fumagalli et al. 2009a; Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Fumagalli et al. 2011; Hancock et al. 2008; Hancock et al. 2010; Hancock et al. 2011; Pozzoli et al. 2010; Prugnolle et al. 2005) . In particular, these approaches were suggested to be particularly useful for detecting selection on standing variation, which is otherwise difficult to identify using more common tests of natural selection (Pennings and Hermisson 2006) .
Among the environmental factors investigated to date, pathogens have exerted the strongest pressure on the human genome (Fumagalli et al. 2011) . These analyses have a clear relevance from an evolutionary point of view, and help explain why specific disorders such as IBD and celiac disease (Abadie et al. 2011; Barreiro and Quintana-Murci 2010; Fumagalli et al. 2009b; Fumagalli et al. 2011; Zhernakova et al. 2010 ) are so prevalent in humans, despite the fitness reduction they cause.
Previous works have shown that, albeit not independent, the diversity of different pathogen groups (i.e. protozoa, bacteria, helminths and viruses) in distinct geographic areas can be regarded as a reliable measure of the selective pressure exerted by these agents, and that their effects can be disentangled (Fumagalli et al. 2009a; Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Fumagalli et al. 2011; Pozzoli et al. 2010; Prugnolle et al. 2005) . We used this same approach to verify whether known variants associated with CD and UC have been targeted by pathogen-driven selective pressure more often than expected; our data indicate that while UC susceptibility loci are not preferential selection targets, about 19% of SNPs associated with CD have been subject to a selective pressure exerted by protozoa. By applying a re-sampling approach, this proportion was compared to that of all GWAS SNPs or to variants that have been associated with immune-mediated/infectious diseases only. This procedure is devised to assess the excess of selected SNPs for CD against variants that share the same biases (i.e. being tag SNPs, and most often identified in European populations), and that have an effect on human phenotypes. In both comparisons the proportion of CD variants selected by protozoa was statistically significant.
Similarly, analysis of GWAS data and a meta-analysis for CD indicated that variants selected by protozoa have stronger association p values compared to variants that have not been targeted by these infectious agents. This was not observed for all other autoimmune diseases we analysed, including UC. A recent large-scale analysis (Fumagalli et al. 2011) identified genes involved in celiac disease (CeD), UC, type 1 diabetes, and multiple sclerosis as being common targets of pathogen-driven selection. Nonetheless, a different approach was used in that study, as the authors did not disentangle the effect of different pathogens, and performed gene-wise analyses. Herein we applied SNP-wise tests, and the data we present are in agreement with a previous study (Fumagalli et al. 2009b) showing that a few variants located in genes encoding interleukins/interleukin receptors and associated with IBD and/or CeD have been targets of pathogen-driven selection.
Unfortunately, no complete GWAS data for CeD is publicly available, so we could not verify whether pathogen-selected SNPs show stronger association with this disease compared to nonselected variants; yet, analysis of GWAS-significant SNPs for CeD revealed no significant enrichment of polymorphisms that correlate with the diversity of any pathogen group (not shown).
Crohn's disease is thought to occur in genetically susceptible individuals as a consequence of disregulated immune recognition of commensal gut flora, which is mainly accounted for by bacterial species. Therefore, protozoa have generally attracted little interest in relation to this disease. Nonetheless, immune response pathways often allow protection against a wide variety of pathogens. For example, mice deficient in Irgm1, a known CD gene, are highly susceptible to infection with both Listeria monocytogenes and Toxoplasma gondii (Collazo et al. 2001) .
Interestingly, recent evidences have indicated T. gondii as a possible environmental trigger/cause of autoimmune diseases, including IBD (Lidar et al. 2009; Shapira et al. 2012 ). This parasite might have a particular interest in relation to CD, as infection of certain mouse strains with Toxoplasma triggers an inflammatory pathology resembling CD (Egan et al. 2011; Egan, Cohen, Denkers 2012 ).
This observation has also led to the proposal that T. gondii infection might be used as a novel experimental model of CD (Denkers 2010; Egan, Cohen, Denkers 2012) . Our data indicate that variants in 8 genes identified in GWASs for CD have been targeted by protozoa-driven selection.
Among these, NOD2 and TYK2 are necessary for clearance of T. gondii in mouse models (Shaw et al. 2003; Shaw et al. 2009 ), while IL23, the ligand of IL23R is essential for the triggering of intestinal inflammation by the parasite (Munoz et al. 2009 ). These observations do not necessarily imply that T. gondii is the selective agent responsible for shaping allele frequencies at these loci.
Indeed, protozoan-transmitted diseases, and malaria in particular, have been shown to represent an exceptionally strong selective pressure for humans (Kwiatkowski 2005; Pozzoli et al. 2010) , and Although GWAS and meta-analyses have unveiled several susceptibility loci for CD, the majority of risk alleles for the disease remain to be identified (Khor, Gardet, Xavier 2011) . A portion of these are thought to be accounted for by small effect variants that do not reach statistical significance in genome-wide analyses ( NSF is a protein involved in vesicle sorting and autophagy (Behrends et al. 2010) . This latter process is central in the clearance of intracellular bacteria, as well as in the pathogenesis of CD (Khor, Gardet, Xavier 2011) . In line with this view, NSF is necessary for the recruitment of VAMP3 (Fig. 2) at sites of Salmonella infection, and for the maturation of bacterium-containing vacuoles (Coppolino et al. 2001) . Notably, the NSF variant we associated with CD has previously been shown to confer risk for Parkinson's disease (Simon-Sanchez et al. 2009 ); thus, NSF joins LRRK2 (Zimprich et al. 2004 ) as a risk gene shared between the two diseases. This is in line with the recent observation that pleiotropy is widespread for complex disease risk loci (Sivakumaran et al. 2011) , and with the description of higher frequency of NOD2 variants in sporadic Parkinson's disease (Bialecka et al. 2007 ).
Finally, ARHGEF2 (also known as GEF-H1) encodes a nucleotide exchange factor for Rac and Rho small GTPases (Ren et al. 1998 ). The gene is involved in multiple cellular processes, including pathogen recognition by NOD1 and NOD2. Specifically, by signaling downstream of NOD2, GEF-H1-mediates the activation of RIP2, a process that is abolished in the presence of the 3020insC variant of NOD2 associated with CD (Zhao et al. 2012) . Similarly, ARHGEF2 participates in sensing muramyl dipeptides through NOD1 and, by activating RHOA (Fig. 2) , induces the NF-κB signaling pathway (Fukazawa et al. 2008) . The interaction between RHOA and ARHGEF2 at tight junctions is also central in regulating paracellular permeability in human colonic epithelia (Samarin et al. 2007) , and enteropathogenic Escherichia coli strains have been shown to hijack GEF-H1 activity to facilitate infection (Matsuzawa et al. 2004) . Interestingly, an increased activation of RHOA has been described in the inflamed intestinal mucosa of CD patients and in rats with experimentally-induced colitis (Segain et al. 2003 ).
Thus, the three genes we have identified have biological functions consistent with their involvement in the pathogenesis of CD and two of them participate in a molecular pathway that contains additional loci previously associated with the disease (VAMP3, (Franke et al. 2010 )) or disregulated in CD patients (RHOA) (Segain et al. 2003) . The network also contains CD28, a co-stimulatory molecule essential for T cell differentiation and survival, and is centred around miR-31. Notably, this microRNA shows higher expression in both unaffected and inflamed colonic tissue from IBD patients compared to controls, with miR-31 abundance being higher in inflamed vs uninflamed IBD tissue (Dalal and Kwon 2010) . Similarly, increased expression of miR-31 was detected in Il10
mice, an animal model of Th1-mediated inflammatory bowel disease, and preceded the ensuing of colonic pathology (Schaefer et al. 2011) .
It is worth noting that we observed both risk and protective alleles for CD to correlate with protozoa diversity; thus, as anticipated elsewhere , the vision whereby alleles that predispose to autoimmunity are maintained in human populations due to their being protective against infections is over-simplistic. Possibly, some risk alleles have increased in frequency as a consequence of the selection operated by protozoa, whereas others might have reached higher representation in areas where the selective pressure exerted by these parasites has been relaxed. This is also in line with the observation that both risk and protective alleles for autoimmune diseases increased in frequency due to selection (Barreiro and Quintana-Murci 2010) . Linkage disequilibrium between SNP pairs was calculated using SNAP (SNP Annotation and Proxy Search; http://www.broadinstitute.org/mpg/snap/ldsearchpw.php) using data for Europeans (CEU);
SNPs showing r 2 >= 0.8 were collapsed in a single locus by randomly selecting one of the two polymorphisms.
Re-sampling experiments for CD and UC SNPs were performed using SNP sets matched for minor allele frequency (MAF); specifically for each CD or UC SNP one GWAS variant with a MAF differing less than 1% was sampled (i.e. we divided MAFs into 50 bins).
Association p values for the WTCCC GWAS for CD (Wellcome Trust Case Control Consortium 2007) were retrieved from the European Genome-phenome Archive (EGA, http://www.ebi.ac.uk/ega/) which is hosted by the EBI, under accessions EGAS00000000006.
Meta-analysis data derive from previous works (Barrett et al. 2008; Franke et al. 2008 ) and available at http://www.broad.mit.edu/~jcbarret/ibd-meta/ and http://www.ibdgenetics.org/downloads.html. GWAS data for the NIDDK study of CD (Rioux et al. 2007 ) were retrieved from the dbGAP website (http://www.ncbi.nlm.nih.gov/gap/). GWAS data for other autoimmune diseases were retrieved either from the EGA (WTCCC1 studies) or from dbGAP. Confidence intervals for the meta-analysis Q-Q plot were calculated using a Moving Block Bootstrap (MBB) re-sampling procedure Keinan and Reich 2010) . This is suitable to correct for the non independence among loci, also taking into account the possibility of an increased level of linkage disequilibrium near the positively selected sites. Chromosome blocks were sampled following a previously described procedure (Fumagalli et al. 2011) and SNPs belonging to the subset S were extracted so as to obtain a sample subset (SS). Each SS was Q-Q plotted as described for the subset S, using the same CFs. For each Q-Q plot point we calculated the distance from the identity line. After repeating the procedure for 1000 samples we obtained a distribution of distances at each CF. We then used the 5th and 95th percentiles of these distributions to plot confidence intervals around the real Q-Q plot data points.
A second analysis was performed on the S set to account for MAF differences in European 
Identification of variants targeted by pathogen-driven selection
The approach used to identify variants selected by different pathogen species has been extensively described elsewhere (Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Pozzoli et al. 2010) . Briefly, it is based on calculating Kendall's correlation coefficient ( )  between allele frequencies of HGDP-CEPH SNPs (Li et al. 2008) and pathogen diversity in the countries where populations included in the Panel live. In order to account for demographic events, each SNP is then assigned a percentile rank in the distribution of  values calculated for all SNPs having a minor allele frequency (MAF) similar (in the 1% range) to that of the SNP being analysed (Fumagalli et al. 2009b; Fumagalli et al. 2010a; Fumagalli et al. 2010b; Pozzoli et al. 2010 
Genome data analysis
Data from the Pilot 1 phase of the 1000 Genomes Project were retrieved from the dedicated website (http://www.1000genomes.org/) (1000 Genomes Project Consortium et al. 2010 . SNP genotypes were organized in a MySQL database. A set of programs was developed to retrieve genotypes from the database and to analyse them according to selected regions/populations. These programs were developed in C++ using the GeCo++ (Cereda et al. 2011 ) and the libsequence (Thornton 2003) 
Genotyping and statistical analysis
Genotyping of all SNPs was performed by TaqMan probe assays (Applied Biosystems, Foster City, CA, USA) using the allelic discrimination real-time PCR method.
All polymorphisms complied to Hardy-Weinberg equilibrium. Association analysis was performed by means of logistic regressions with sex as a covariate using PLINK (Purcell et al. 2007 ).
Network construction
Biological network analysis was performed with Ingenuity Pathways Analysis (IPA) software using an unsupervised analysis (www.ingenuity.com). IPA builds networks by querying the Ingenuity Pathways Knowledge Base for interactions between the identified genes and all other gene objects stored in the knowledge base; it then generates networks with a maximum node size of 35 genes/proteins. We used the three genes significantly associated with CD as the input set and the Ingenuity Knowledge Base (genes and endogenous chemicals) as the reference set (as of April 2012). We considered both direct and indirect relationships (confidence = experimentally observed or high). Only relationships observed in human, mouse or rat were considered. 
